Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Stocks

Markets Flip as Earnings Season Heats Up

by July 22, 2023
July 22, 2023
Markets Flip as Earnings Season Heats Up

Last week, the number of companies reporting earnings expanded, with heavyweight names Tesla (TSLA) and Netflix (NFLX) getting the most attention. Both companies sold off sharply on Thursday despite beating estimates. The selling spread to other Nasdaq stocks after two heavyweight Semiconductor companies signaled continued weakness in the chip market.

Stocks from beaten-down areas of the market were treated quite differently, however, with healthcare giants Johnson & Johnson (JNJ) and Abbott Labs (ABT) spiking higher after beating guidance and raising their full-year outlook. Bank stocks — another area that’s underperformed amid a crisis — were the biggest winners, as they continued to rally on earnings even if they missed views.

The result was a week where the worst performing sectors year-to-date were last week’s top performeres, while winning sectors were at the bottom.

Could it be that investors are paying attention to valuations as earnings reports roll in? Next week will certainly test this possibility, with four mega-cap companies due to report while a host of additional bank and healthcare companies release results. Microsoft (MSFT), Meta Platform (META), Alphabet (GOOGL), and Amazon (AMZN) are also seeing a rebalance in their Nasdaq 100 weighting on Monday, in addition to their reports later in the week.

Daily Chart of Healthcare Sector

Above is a daily chart of the Healthcare sector after last week’s 3.5% rally pushed the group out of a 3-month base on heavy volume. With the sector poised to trade higher, I believe that pharmaceutical giant Novo Nordisk (NVO) deserves a close look after last week’s move back above resistance at its 50-day moving average.

NVO sells two weight loss drugs while also working on additional treatments that are seeing positive results in trial studies. Today, Wall Street firm Morgan Stanley raised their forecast for annual sales of weight loss drugs to $77 billion, as patient demand for the medicines has outstripped supply amid a social media frenzy.

Daily Chart of Novo Nordisk (NVO)

NVO’s downtrend reversal occurred on above-average volume, while the MACD has just entered positive territory. Both positive characteristics join an already-positive RSI, as can be seen on the daily chart above.

Earnings season has always been a critical period for the markets, as not only is investor sentiment revealed based on responses to results, sector rotation such as last week’s move into Healthcare can take place. If you’d like to be alerted to these critical shifts, use this link here to trial my twice weekly MEM Edge Report. We alerted subscribers to January’s move into Semiconductors while highlighting Nvidia as a buy candidate. The stock has gained 158% since then!

Warm Regards,

Mary Ellen McGonagle, MEM Investment Research

0
FacebookTwitterGoogle +Pinterest
previous post
MEM TV: Tech Stock Decline Spooks Market
next post
Alabama lawmakers reject 2nd Black majority Congressional district, increase to 40% after Supreme Court ruling

You may also like

Market Stayed Strong During Difficult Week

July 29, 2022

Decoding Bear Markets, Divergences, & More! A Q&A...

November 10, 2023

Putting a Mean-Reversion Strategy Into Practice

January 8, 2024

Don’t Miss the Move Into These NEW Areas!

December 16, 2023

Investing with the Trend: Conclusions

June 20, 2024

The Ord Oracle November 28, 2023

November 29, 2023

Want More Market Insights and Trade Ideas? Try...

June 10, 2023

Does “NoGo” for the S&P = NEW Opportunities...

August 17, 2023

Key Levels for the FAANG Stocks

April 7, 2023

Stock Price Divergence and Potential Signs of Risk!

January 25, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • The New Retaliation Tax, Section 899

      June 10, 2025
    • M&S reopens online orders after cyberattack disruption

      June 10, 2025
    • UK payrolls see biggest drop since covid as wage growth slows and job market weakens

      June 10, 2025
    • Why AI and green tech are vital to SME growth in 2025

      June 10, 2025
    • Yes, it’s great to get PR coverage – until it’s locked behind a bloody paywall

      June 10, 2025
    • We have to act now to keep AI from becoming a far-left Trojan Horse

      June 10, 2025

    Categories

    • Business (8,174)
    • Investing (2,022)
    • Politics (15,580)
    • Stocks (3,138)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved